Baptist Medical Center

Jacksonville, Florida 32256

2 studies enrolling now · 37 studies all time

What they study most

Alzheimer Disease, Aneurysms, Arterial Occlusive Disease, Atrial Fibrillation, Atrial Fibrillation (AF), Atrial Septal Defect Secundum, Bleeding, Bradycardia, Breast Cancer, Breast Neoplasms, Breast Neoplasms, Hormone Receptor Positive/HER2 Negative, Breast Neoplasms, Triple-Negative

Studies at this site

• ATLAS (AltaValve) Pivotal Trial — Recruiting now
• WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment) — Recruiting now
• Abbott Medical - VERITAS Study — Running, not enrolling
• SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
• ADVENT Post Approval Study — Running, not enrolling
• SIMPLAAFY Clinical Trial — Running, not enrolling
• A Study to Look at Performance of MICRUSFRAME and GALAXY Coils for the Treatment of Intracranial Aneurysms — Completed
• Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA — Completed
• Aveir DR i2i Study — Completed
• MitraClip REPAIR MR Study — Running, not enrolling
• AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
• Amplatzer Amulet LAAO vs. NOAC — Running, not enrolling
• Amulet™ ADVANCE LAA — Running, not enrolling
• CERENOVUS Neurothrombectomy Devices Registry — Completed
• Suturable DuraGen™ PMCF Study — Completed
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
• Patient Preferences for Leadless Pacemakers — Completed
• Reveal LINQ for Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Investigation of Clot in Ischemic Stroke and Hematoma Evacuation — Completed
• Study to Evaluate the Safety and Antitumor Activity of CX-2009 Monotherapy and in Combination With CX-072 in Advanced Breast Cancer — Completed
• Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation — Completed
• Precision Event Monitoring for Patients With Heart Failure Using HeartLogic — Completed
• Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 — Completed
• Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
• Assessment of the Embolization of Neurovascular Lesions Using the Penumbra Smart Coil — Completed
• BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease — Completed
• Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight — Completed
• ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study — Stopped early
• A Study Of Inotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose Chemotherapy — Stopped early
• Evaluation of Automatic Threshold Algorithms — Completed
• Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) — Completed
• Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II) — Completed
• Reversal of Dabigatran Anticoagulant Effect With Idarucizumab — Completed
• AXIOS Stent With Electrocautery Enhanced Delivery System — Completed
• TAXUS Libertē Post Approval Study — Completed
• Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures — Completed